B

Biohit Oyj
OMXH:BIOBV

Watchlist Manager
Biohit Oyj
OMXH:BIOBV
Watchlist
Price: 2.35 EUR -3.69%
Market Cap: 35.5m EUR
Have any thoughts about
Biohit Oyj?
Write Note

Wall Street
Price Targets

BIOBV Price Targets Summary
Biohit Oyj

Wall Street analysts forecast BIOBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOBV is 2.75 EUR with a low forecast of 2.73 EUR and a high forecast of 2.84 EUR.

Lowest
Price Target
2.73 EUR
16% Upside
Average
Price Target
2.75 EUR
17% Upside
Highest
Price Target
2.84 EUR
21% Upside
Biohit Oyj Competitors:
Price Targets
7817
Paramount Bed Holdings Co Ltd
15% Upside
9996
Peijia Medical Ltd
31% Upside
IDXX
IDEXX Laboratories Inc
31% Upside
688677
Qingdao NovelBeam Technology Co Ltd
73% Upside
300633
SonoScape Medical Corp
29% Upside
BSX
Boston Scientific Corp
10% Upside
OFIX
Orthofix Medical Inc
28% Upside
4543
Terumo Corp
17% Upside

Revenue
Forecast

Revenue Estimate
Biohit Oyj

For the last 8 years the compound annual growth rate for Biohit Oyj's revenue is 10%. The projected CAGR for the next 3 years is 16%.

10%
Past Growth
16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biohit Oyj

The compound annual growth rate of Biohit Oyj's operating income for the next 3 years is 19%.

N/A
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Biohit Oyj

The compound annual growth rate of Biohit Oyj's net income for the next 3 years is 10%.

N/A
Past Growth
10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOBV's stock price target?
Price Target
2.75 EUR

According to Wall Street analysts, the average 1-year price target for BIOBV is 2.75 EUR with a low forecast of 2.73 EUR and a high forecast of 2.84 EUR.

What is Biohit Oyj's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Biohit Oyj's revenue is 10%. The projected CAGR for the next 3 years is 16%.

What is Biohit Oyj's Operating Income forecast?
Projected CAGR
19%

The compound annual growth rate of Biohit Oyj's operating income for the next 3 years is 19%.

What is Biohit Oyj's Net Income forecast?
Projected CAGR
10%

The compound annual growth rate of Biohit Oyj's net income for the next 3 years is 10%.

Back to Top